Biogen favored to win against Icahn in proxy fight

BOSTON (Reuters) - Shareholders of Biogen Idec Inc will meet shortly to decide whether one of the world's biggest and oldest biotechnology companies should remain independent or be put up for sale by billionaire investor Carl Icahn. 2 months ago